Company intelligence / Profile preview

Norilia

Ownership: Private
Employees: ~45
Development stage: Commercial

Overview

Norilia commercializes value-added products from meat and egg industry co-streams ("plus-products"), using advanced biotechnology such as enzymatic hydrolysis and fermentation. It has developed a trade-secret protected gentle process to extract high-quality proteins from poultry. The company also collaborates on innovative projects like an organic adhesive bandage made of eggshell membrane for chronic sore healing. Most products are already commercialized globally; no clinical trial pipeline as it does not develop pharmaceuticals.

Therapeutic areas: Metabolic DisordersDermatology
Modalities: ProteinEnzymatic hydrolysateEggshell membrane (for wound healing)Animal by-product derived ingredients
Industry: Chemicals & Materials

Partnerships

BiovotecNofima ASFelleskjøpet AgriSFI Industrial Biotechnology consortiumARRIVAL project

Beyond the preview

Go deeper on Norilia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norilia.

Explore the full profile